NOVEMBER 6, 2008 -- Syneron Medical Ltd.(Yokneam, Israel), developer of elos ("electro-optical synergy") medical aesthetic devices, has agreed to acquire laser technology development and research firm Inlight Corp. (San Diego, CA). As part of the agreement, Inlight president and co-founder Shlomo Assa will join the Syneron management team. Assa, who holds multiple U.S. patents for laser-based technology, has deep experience in the laser device industry, having previously worked with such companies as Laser Industries Ltd.
Leveraging Inlight technology, Syneron plans to develop highly competitive skin rejuvenation products, and launch the first of these in 2009. Syneron is known for its Matrix RF fractional laser soft-tissue ablation and skin resurfacing products, its LipoLite laser-assisted liposuction-alternative technology, and VelaShape cellulite reduction/body contouring offerings.
"With the expertise offered by Inlight, we have assembled a powerful team for enhancing the capabilities, applications and success of laser technology for our customers and partners," said Syneron CEO Doron Gerstel. "This acquisition represents an important expansion of our product development presence in the United States and serves as a foundation for our commitment to improve and continue to diversify our product offerings."
The Inlight acquisition is the second major product/technology investment for Syneron in 2008. In February, Syneron invested in Rakuto Bio Technologies Ltd. (RBT), an Israeli-based start-up, to develop an advanced whole skin complexion whitening treatment.
Syneron manufactures and distributes medical aesthetic devices powered by the proprietary, patented elos combined-energy technology of bi-polar radio frequency and light.